Pramlintide
- Generic Name
- Pramlintide
- Brand Names
- Symlin
- Drug Type
- Small Molecule
- Chemical Formula
- C171H267N51O53S2
- CAS Number
- 151126-32-8
- Unique Ingredient Identifier
- D3FM8FA78T
- Background
Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.
- Indication
用于1型和2型糖尿病的辅助治疗。
- Associated Conditions
- Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
- Associated Therapies
- -
Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2008-01-16
- Lead Sponsor
- Ludwig-Maximilians - University of Munich
- Target Recruit Count
- 27
- Registration Number
- NCT00489645
The Effect of Pramlintide on Meal Time Insulin Bolus
Not Applicable
Completed
- Conditions
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2009-04-03
- Lead Sponsor
- Diabetes Care Center
- Target Recruit Count
- 12
- Registration Number
- NCT00460304
Continuous Subcutaneous Infusion of Pramlintide and Insulin
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-02-15
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT00291772
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00206297
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath